Sign In
Buy VTRS
$16.39
+0.120 (+0.738%)
At Close: Jul 13, 2026
Viatris (VTRS) Beats Q3 Earnings and Revenue Estimates
09:30am, Thursday, 07'th Nov 2024
Viatris (VTRS) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.68 per share. This compares to earnings of $0.78 per share a year ago.
Xanax maker Viatris beats quarterly estimates on demand for new generic drugs
08:57am, Thursday, 07'th Nov 2024
Drugmaker Viatris beat Wall Street estimates for third-quarter profit and revenue on Thursday, helped by strong demand for its new generic asthma and ADHD drugs, among others, sending its shares up 2.
What's in Store for These 5 Drug & Biotech Stocks in Q3 Earnings?
04:00pm, Tuesday, 05'th Nov 2024
Let us look at five large biotech and generic drug companies, NVO, GILD, MRNA, VTRS and TEVA, which are gearing up for their earnings releases this week.
Viatris Announces Third Quarter 2024 Dividend
06:59am, Tuesday, 05'th Nov 2024
PITTSBURGH , Nov. 5, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that on November 4, 2024, its Board of Directors declared a quarterly dividend of $0.12 per share for each issued
Unveiling Viatris (VTRS) Q3 Outlook: Wall Street Estimates for Key Metrics
10:22am, Monday, 04'th Nov 2024
Besides Wall Street's top -and-bottom-line estimates for Viatris (VTRS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qu
Viatris Named to Forbes' World's Top Companies for Women 2024 List
12:00pm, Tuesday, 29'th Oct 2024
PITTSBURGH , Oct. 29, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has been named to Forbes' World's Top Companies for Women 2024 List. Thi
Viatris to Participate in the UBS Global Healthcare Conference and Jefferies London Healthcare Conference
09:00am, Tuesday, 29'th Oct 2024
PITTSBURGH , Oct. 29, 2024 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the company will participate in two upcoming healthcare conferences. Details
Idorsia announces financial results for the first nine months of 2024
02:00am, Tuesday, 29'th Oct 2024
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – October 29, 2024 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first nine months of 2024.
Viatris Ahead Of Q3 Earnings: No Longer A 'Screaming' Bargain, But Still A Buy
03:56pm, Tuesday, 22'nd Oct 2024
Viatris Inc. stock has experienced significant volatility since its 2020 inception, driven by disappointing early performance, asset sales, and fluctuating market expectations. Despite low P/E and P/S
Lexicon Announces Exclusive Licensing Agreement With Viatris for Sotagliflozin in All Markets Outside of the U.S. and Europe
04:35pm, Wednesday, 16'th Oct 2024
-Lexicon to receive an upfront payment of $25 million and the potential for contingent regulatory and commercial milestone payments -Lexicon to receive an upfront payment of $25 million and the potent
Viatris Announces Exclusive Licensing Agreement with Lexicon Pharmaceuticals for Sotagliflozin in all Markets Outside of the U.S. and Europe
04:34pm, Wednesday, 16'th Oct 2024
Continues to Expand Viatris' Innovative Portfolio in Cardiovascular Diseases Leverages Viatris' Unique Global Infrastructure and Expertise Includes Opportunities to Leverage the Potential of Sotagl
Viatris Announces Positive Top-line Results from Phase 3 Study of EFFEXOR® in Japanese Adults with Generalized Anxiety Disorder (GAD)
06:59am, Wednesday, 09'th Oct 2024
Treatment with once-daily EFFEXOR® met primary and all secondary efficacy endpoints in outpatient adults with GAD EFFEXOR® was generally well tolerated, consistent with its known safety profile Phar
Viatris Named to Forbes' Annual List of the World's Best Employers for the Fourth Year in a Row
11:00am, Tuesday, 08'th Oct 2024
PITTSBURGH , Oct. 8, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has been named to Forbes' list of World's Best Employers 2024. This is the
Viatris Announces the Pricing Terms of Maximum Tender Offer
11:30am, Wednesday, 18'th Sep 2024
PITTSBURGH , Sept. 18, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS, "Viatris" or the "Company") announced today the pricing terms of the previously announced cash tender offer (the "Maximum Tender
Viatris Announces Early Tender Results and Increase of Pending Maximum Tender Offer
08:45pm, Tuesday, 17'th Sep 2024
PITTSBURGH , Sept. 17, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS, "Viatris" or the "Company") announced today the early tender results of the previously announced cash tender offer (the "Maximum
